Clinical trials: Plasmodium Vivax Malaria Without Complication
Plasmodium Vivax Malaria Without Complication
Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia
Both artemether-lumefantrine and chloroquine are currently used and recommended by Malaysian Ministry of Health as blood stage treatments for non-severe P. vivax and P. knowlesi malaria.
- Trial name
- PRIMAL (NCT02348788)
- Testing
- Artemether-lumefantrine + Primaquine, Chloroquine + Primaquine
- Where
- 3 sites in Malaysia
- Volunteers
- 98 people
- Sponsor
- Menzies School of Health Research
Plasmodium Vivax Malaria Without Complication, Plasmodium Falciparum Malaria (Uncomplicated)
Ethiopian Antimalarial Therapeutic Efficacy Study 2026
Background: The WHO recommends monitoring the efficacy of antimalarial drugs at least once every two years after implementation.
- Trial name
- TES2026 (NCT07840898)
- Testing
- Artemether-Lumefantrine + Primaquine and Chloroquine + Primaquine
- Where
- Ethiopia
- Volunteers
- 1,200 people
- Sponsor
- Ethiopian Public Health Institute